Senior insider sale
EVP, Chief Technical Officer at INTELLIA THERAPEUTICS, INC. — senior position signals high conviction
$865.7K
68.71K shares
What this filing means
CLARK ELIANA plans to sell 68.71K shares of INTELLIA THERAPEUTICS, INC. valued at approximately $865.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/5/2026ACC: 0001950047-26-010054
Officer· EVP, Chief Technical Officer
Since Feb 2022
68.71K
Shares to sell
$865.7K
Approx. market value
57.75K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
10/5/2026
57.75KTotal acquired57.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/5/2026 | Stock Option Exercise Cash | 57.75K | — |
| Total | 57.75K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10.96K
Market value
$129.4K
8/10/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
57.75K
Market value
$736.3K
10/5/2026
Total
Units
68.71K
Value
$865.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/10/2026 | 10.96K | $129.4K | — | Completed |
| Planned — Approximate Date | ||||
10/5/2026 | 57.75K | $736.3K | NASDAQ | Planned |
| Total | 68.71K | $865.7K | ||